CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week 稳定性冠心病诊断与治疗指南 Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States Cardiac Troponin Elevation in Patients Without a Specific Diagnosis Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction Correlation between frequency-domain optical coherence tomography and fractional flow reserve in angiographically-intermediate coronary lesions The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG Large-Bore Radial Access for Complex PCI: A Flash of COLOR With Some Shades of Grey

Review ArticleVolume 74, Issue 6, 13 August 2019, Pages 804-813

JOURNAL:J Am Coll Cardiol. Article Link

Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week

F Triposkiadis, A Xanthopoulos, J Butler et al. Keywords: aging; amyloidosis; comorbidities; heart failure; risk factors

ABSTRACT


Heart failure (HF) is a clinical syndrome that usually develops in the elderly. Complex interactions of the cardiovascular aging process with risk factors (obesity, hypertension, and atherosclerosis), comorbidities (anemia, chronic kidney disease, diabetes, and so on), and disease modifiers (sex, genes, others) contribute to the development of HF phenotype and outcome. A conglomerate of cellular and molecular mechanisms underlies the effects of aging on cardiovascular function, the most important being excessive oxidative stress and chronic low-grade inflammation superimposed on the limited cardiac regeneration capacity. Notably, a sizeable percentage of elderly HF patients have cardiac amyloidosis, an HF precipitator. This review summarizes the current published data on the mechanisms of cardiovascular aging as they contribute to the development of HF phenotype and outcome.